Voice Analysis for Monitoring Patients With Heart Failure

This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during their hospital stay, from admission until discharge. Alongside voice data, additional clinical information such as left ventricular ejection fraction, NTpro-BNP levels, and ECG-data will be collected for comprehensive analysis. The study's goal is to identify voice-based indicators of heart failure progression, with the potential to enhance remote monitoring and self-management strategies for heart failure patients.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Heart Failure Cardiovascular Diseases Heart Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Deutsches Herzzentrum der Charité, Berlin, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinically diagnosed with Acutely Decompensated Heart Failure.
At least 18 years of age.

Exclusion criteria

Disabling mental diseases (e.g., Alzheimer's disease)
Clinically diagnosed chronic obstructive pulmonary disease (COPD)
Treatment in ICU or IMU
Dialysis treatment
Previous operations on organs involved in generation of voice (vocal tract, vocal folds, etc.)
Neurodegenerative diseases
Pregnancy
Inability to provide consent

Treatment and study plan

Primary outcomes

Change in vocal characteristics from admission to discharge and their correlation with heart failure severity markers.

Time frame: Hospital stay

The primary endpoint is the change in vocal characteristics from admission to discharge, and its correlation with clinical markers of heart failure severity, such as weight change from admission to discharge, NTpro-BNP levels, ECG-parameters, and left ventricular ejection fraction (LVEF).

Study contacts

Contact information is provided by the study sponsor or research team.

Leonhard Riehle, MD

CONTACT

[email protected]

+49 32 221093495

Sponsors and collaborators

Lead sponsor

Noah Labs

Industry

Collaborators

Charite University, Berlin, Germany
Mayo Clinic

Registry information

Official study title

A Pilot Study on AI-Based Voice Analysis for Monitoring Patients Hospitalized With Acute Decompensated Heart Failure

Acronym: VAMP-HF

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2024
First posted: Aug 22, 2024
Registry last updated: Aug 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting